SCHEMBL30746620

SCHEMBL30746620

CNS(=O)(=O)Nc1ccc(Cc2cncc(Nc3ccc(Cl)cc3F)c2C)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.39
▸ KDR P35968 6/20 0.38
▸ FLT1 P17948 5/20 0.38
▸ NUDT1 P36639 4/20 0.38
▸ FGFR1 P11362 4/20 0.38
▸ FLT4 P35916 2/20 0.37
▸ EPHB2 P29323 1/20 0.37
▸ CSF1R P07333 1/20 0.36
▸ ERBB2 P04626 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ FPR1 P21462 1/20 0.35
▸ P2RX7 Q99572 1/20 0.35
▸ CYP17A1 P05093 1/20 0.34
▸ CMA1 P23946 1/20 0.34
▸ PI4KB Q9UBF8 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985148 1.00 EGFR (0.39) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL30746656 0.84 ALDH1A1 (0.42) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL26985170 0.84 ALDH1A1 (0.42) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL30746601 0.81 P2RX3 (0.40) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL26984883 0.81 P2RX3 (0.40) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL26984976 0.80 NUDT1 (0.38) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL30746381 0.80 NUDT1 (0.38) EGFRKDRFLT1NUDT1FGFR1
SCHEMBL31613381 0.79 CYP17A1 (0.36) NUDT1CSF1RCYP17A1HTT
SCHEMBL26985334 0.78 RAF1 (0.41) KDRFLT1FGFR1SRCHTT
SCHEMBL30746584 0.78 NUDT1 (0.40) KDRFLT1NUDT1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback